Co-investigator in Phase-III trial of NuvocidTM (Oritavancin) at single or infrequent doses for the treatment of complicated skin and skin structures infections, TAR-ORI-SD001, conducted by Targanta Therapeutics Corporation, Indiana, US.
Co-investigator in Pilot project “Characterization of epigenetically deregulated genes in colorectal adenomas/carcinomas using next generation sequencing technologies for development of novel biomarkers” funded by Department of Biotechnology, Ministry for Science and Technology, Government of India. (Ongoing)

Appointment